Digital Therapeutics (DTx)

“Digital Health” continues to evolve quickly, with technological innovations providing new opportunities for patients, providers, and payers. Despite the clear opportunity to improve health through digitally-enabled interventions, it remains challenging to achieve commercial success for digital products. Key challenges include securing favorable market access and reimbursement, incorporating digital tools into provider workflows, and optimizing the patient experience.

Informed by decades of experience developing go-to-market strategies for health technologies (pharma, biotech, MedTech, DTx, etc.), our team brings deep expertise in value demonstration, access and reimbursement, pricing, demand generation, and business model development to overcome the uptake and payment hurdles facing emerging digital technologies.

Our focus areas


  • 01
    Market access strategy for a device/App combination in diabetes
    CRA’s approach to the healthcare market access launch strategy:  Conducted a thorough healthcare market access landscape analysis in six countries covering...
    View engagement
  • 02
    Five-year vision in prescription digital therapeutics
    CRA approach Facilitated a two-day healthcare corporate strategy workshop with the prescription digital therapeutics leadership team to debate and align on...
    View engagement
  • 03
    Value proposition reimbursement pathways for a DTx
    CRA approach Evaluated relevant digital therapeutic analogues to establish the likely reimbursement and funding pathways for a novel eHealth...
    View engagement

Subscribe to receive our latest Insights.